Omega Diagnostics Group PLC | Mutual Funds

Mutual Funds that own Omega Diagnostics Group PLC

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Cavendish Investments Funds - AIM Fund
5,069,126
3.99%
0
0.97%
07/31/2018
Unicorn AIM VCT Plc
4,266,750
3.36%
0
0.33%
08/31/2018
Artemis VCT Plc
3,011,206
2.37%
-89,298
0.99%
09/30/2017
Octopus AIM VCT 2 Plc
2,820,488
2.22%
4,105
0.55%
05/31/2017
Hygea VCT Plc
2,293,868
1.81%
50,487
5.99%
06/30/2017
Hargreave Hale AIM VCT 2 Plc
825,964
0.65%
-13,733
0.24%
02/28/2017
Maven Income & Growth VCT 5 Plc
632,757
0.5%
-7,248
0.3%
11/30/2017
Mobeus Income & Growth VCT Plc
0
0%
-1,997,225
0%
06/30/2017
Octopus AIM VCT Plc
0
0%
-3,670,980
0%
08/31/2017
Oryx International Growth Fund Ltd.
0
0%
-4,731,473
0%
03/31/2017

About Omega Diagnostics Group

View Profile
Address
Omega House
Alva Scotland FK12 5DQ
United Kingdom
Employees -
Website http://omegadiagnostics.com
Updated 07/08/2019
Omega Diagnostics Group Plc is a holding company, which engages in the manufacture, development, and distribution of medical diagnostics products. It operates through the following segments: Allergy and Autoimmune, Food Intolerance, and Infectious Disease. The Allergy and Autoimmune segment involves in the research, development, production and marketing of in-vitro allergy and autoimmune tests.